Revance Therapeutics Inc (RVNC)
3.08
+0.01
(+0.33%)
USD |
NASDAQ |
Dec 20, 16:00
3.05
-0.03
(-0.97%)
After-Hours: 20:00
Revance Therapeutics Profit Margin (Quarterly): -63.65% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | -367.5% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Ligand Pharmaceuticals Inc | -13.84% |
| MEI Pharma Inc | -- |
| Cellectar Biosciences Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -37.25% |
| Return on Invested Capital | -61.49% |
| Gross Profit Margin (Quarterly) | 70.55% |
| Operating Margin (Quarterly) | -53.87% |
| Return on Net Operating Assets | -97.02% |